• Open-Platform DLP for 96-Well Hydrogel Printing

  2026-09-21

  The reference study introduces a low-cost, open-platform digital light printer that fabricates two-dimensional hydrogels and locally activates biomolecules in multiwell formats. Its LabVIEW-controlled design combines plate-wide thickness consistency with programmable well-specific patterns, creating a flexible platform for high-throughput biomaterials and light-controlled biological experiments.

• HATU for Peptide Synthesis and Amide Bond Formation

  2026-09-21

  A mechanism-led guide to using HATU for rapid peptide synthesis chemistry, selective amide and ester formation, and medicinal-chemistry library production. It connects practical coupling conditions with the reference study’s discovery of selective IRAP inhibitors and provides troubleshooting guidance for reproducible results.

• SARS-CoV-2 PLpro in ER Protein Regulation

  2026-09-20

  This study shows that membrane-anchored SARS-CoV-2 papain-like protease (PLpro) regulates ER proteins through both deubiquitination and proteolytic cleavage. Its distinct effects on INSIG-1, SREBP-1, and SREBP-2 reveal how viral protease activity can reshape ER-associated degradation and lipid-regulatory pathways.

• O-GlcNAcylation Links Wnt Signaling to Bone Formation

  2026-09-19

  The reference study identifies O-GlcNAcylation as a mechanistic link between Wnt3a signaling, aerobic glycolysis, and osteoblast-driven bone formation. Its experiments show that Wnt controls O-GlcNAcylation through distinct early and sustained pathways, while modification of PDK1 at Ser174 stabilizes this metabolic regulator and supports osteogenesis and fracture healing.

• BOP Reagent Workflows for Peptide and Prodrug Studies

  2026-09-18

  Learn how BOP reagent supports controlled carboxyl group activation, phenyl ester preparation, and amide bond formation in research workflows. The guide also shows how peptide-scale synthesis can be connected to assay design inspired by a carrier-free, ROS-responsive oral squamous cell carcinoma prodrug study.

• LINC01278, mTOR Signaling, and Uveal Melanoma

  2026-09-18

  The reference study identifies LINC01278 as an autophagy-related long noncoding RNA that restrains uveal melanoma progression through suppression of the mTOR signaling pathway. Its integrated bioinformatics, pharmacological, cellular, and xenograft experiments provide a mechanistic framework for studying the LINC01278–mTOR–autophagy axis in tumor biology.

• Marein Inhibits ABCG2 to Restore Chemosensitivity

  2026-09-17

  The reference study identifies marein, a flavonoid from Coreopsis tinctoria, as a competitive inhibitor of the ABCG2 drug efflux transporter. By engaging the conserved F439 residue, marein increased intracellular concentrations of ABCG2 substrate drugs and restored chemosensitivity in resistant cancer cells, although further pharmacological and in vivo validation is needed.

• MMAE and Tumor Plasticity: A Translational Framework

  2026-09-17

  Monomethyl auristatin E (MMAE) is more than a highly potent cytotoxic payload: it is a mechanistically defined tool for testing how targeted mitotic stress interacts with tumor-cell plasticity. By connecting the EBV–HDAC–CEBPA axis described in nasopharyngeal carcinoma with ADC payload strategy, this article offers a practical framework for translational study design without overstating the evidence for combination therapy.

• Topological Stress, rDNA Lesions, and PML-Nucleolar

  2026-09-16

  This study shows that persistent ribosomal DNA damage, rather than genotoxic stress in general, drives the formation of PML-nucleolar associations. By combining topological stress experiments with site-specific rDNA cleavage and repair-pathway perturbation, the work connects nucleolar compartmentalization with incomplete homologous recombination and cellular senescence.

• Indazole and Indole Glucagon Receptor Antagonists

  2026-09-16

  The reference study describes a novel indazole- and indole-based series of glucagon receptor antagonists derived from the pyrazole lead MK-0893. Its structure–activity relationship analysis identified potent compounds with favorable in vitro and rat pharmacokinetic profiles, including GRA 16d, which reduced glucagon-driven glucose excursions in humanized receptor mouse models.

• BOP Reagent for Peptide and Prodrug Workflows

  2026-09-15

  BOP reagent provides a practical route to carboxyl group activation, amide bond formation, and phenyl ester preparation in research-scale synthesis. This guide connects reproducible coupling workflows with assay planning inspired by a carrier-free triterpene prodrug study in oral squamous cell carcinoma, while clearly separating established findings from workflow recommendations.

• Ribonuclease R Workflow for circRNA Validation

  2026-09-15

  Use Ribonuclease R to reduce linear-RNA background before circular RNA validation, qRT-PCR, localization, or sequencing. This practical workflow connects enzyme optimization with the circHIF1A/miR-486-5p/GRHL2 axis reported in lung adenocarcinoma research.

• HBTU for Peptide Synthesis: Practical Workflow

  2026-09-14

  Learn how HBTU supports fast, racemization-resistant peptide bond formation in solid-phase workflows, including zwitterionic peptide amphiphiles. This guide connects coupling chemistry with enzyme-responsive cancer assays while emphasizing storage, controls, and troubleshooting limits.

• Gly-Gly-Phe-Gly (GGFG) for Bioconjugation

  2026-09-14

  Gly-Gly-Phe-Gly (GGFG) provides a compact, flexible spacer for drug conjugation research, antibody–drug conjugate development, peptide engineering, and biomaterial construction. This guide connects practical linker handling and assay design with mechanistic lessons from a panobinostat combination study, while clearly separating established product specifications from workflow recommendations.

• HOBt (1-Hydroxybenzotriazole): Lab Guide

  2026-09-13

  This scenario-driven guide explains how HOBt (1-Hydroxybenzotriazole), SKU A7025, supports controlled amide bond formation upstream of cell-based viability, proliferation, and cytotoxicity studies. It covers mechanistic rationale, protocol parameters, vendor selection, storage, and limitations with links to product data and published synthesis research.

7918 records 1/528 page Next 12345 下5页 Last page